Chronic Constipation Treatment Drugs Market: Global Market Growth, Trends, and Forecast

The Chronic Constipation Treatment Drugs Market is witnessing steady growth as the prevalence of chronic constipation increases worldwide. According to WiseGuyReports, the market was valued at USD 3.0 billion in 2025 and is projected to reach USD 4.5 billion by 2035, representing a CAGR of 4.3% during the forecast period.

Increasing awareness of gastrointestinal health, changing lifestyles, dietary patterns, and the growing geriatric population are contributing to demand for effective constipation treatments. Pharmaceutical companies are focusing on developing medications that provide improved efficacy, tolerability, and patient convenience.

The market includes several drug classes, including stool softeners, osmotic laxatives, stimulant laxatives, and guanylate cyclase-C agonists. Among these, osmotic laxatives represent an important segment because of their established use in constipation management. Oral administration is also expected to remain a preferred route because of convenience and patient acceptance.

North America currently leads the market due to developed healthcare infrastructure, high healthcare expenditure, and greater awareness of gastrointestinal disorders. Asia-Pacific is expected to provide attractive growth opportunities because of expanding healthcare access and increasing awareness.

Overall, continued pharmaceutical innovation, increasing treatment demand, and growing healthcare investment are expected to support the long-term expansion of the Chronic Constipation Treatment Drugs Market.